Company profile for Zylo Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Zylö Therapeutics has an innovative sustained-release topical delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented xerogel-derived silica particles, called Z-pods™, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration. The human body needs Nitric Oxide [NO],...
Zylö Therapeutics has an innovative sustained-release topical delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented xerogel-derived silica particles, called Z-pods™, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration. The human body needs Nitric Oxide [NO], but produces it at a declining rate, such that a 60-year-old is at about 15%; this results in a range of disorders including stamina issues, cardiovascular issues, wound-healing issues, and ED issues.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
105A Ben Hamby Rd., Greenville, SC 29615
Telephone
Telephone
858.775.6710
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/13/2980569/0/en/Zyl%C3%B6-s-Powered-by-Z-pod-technology-named-twice-as-a-finalist-in-the-prestigious-C-T-All%C4%93-Awards.html

GLOBENEWSWIRE
13 Nov 2024

https://www.globenewswire.com/news-release/2024/04/17/2864480/0/en/Zyl%C3%B6-announces-the-creation-and-spinout-of-Atticus-Pharma-Inc.html

GLOBENEWSWIRE
17 Apr 2024

https://www.globenewswire.com//news-release/2024/02/06/2824688/0/en/Zyl%C3%B6-s-Powered-by-Z-pods-technology-incorporated-into-BosleyMD-s-new-product-line.html

GLOBENEWSWIRE
06 Feb 2024

https://www.globenewswire.com//news-release/2023/10/03/2753638/0/en/Zyl%C3%B6-accepted-into-NYU-s-exclusive-Endless-Frontier-Labs-mentorship-program.html

GLOBENEWSWIRE
03 Oct 2023

https://www.globenewswire.com//news-release/2023/09/27/2750374/0/en/Zyl%C3%B6-s-Powered-By-Z-pod-Technology-Featured-in-Peer-Reviewed-Paper-Published-in-Experimental-Dermatology.html

GLOBENEWSWIRE
27 Sep 2023

https://www.prnewswire.com/news-releases/endocannabinoid-pathway-targeted-drug-demonstrates-proof-of-concept-efficacy-in-a-cutaneous-lupus-erythematosus-mouse-model-301196588.html

PRNEWSWIRE
22 Dec 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty